Clinical Trials Directory

Trials / Conditions / Shock, Septic

Shock, Septic

75 registered clinical trials studyying Shock, Septic12 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingSevoflurane Sedation in Patients With Septic Shock
NCT03643367
University of ZurichPhase 2
TerminatedVasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator
NCT06426407
The Cleveland Clinic
Not Yet Recruiting"Mini Fluid Challenge Assessment: a Comparison Among Three Hemodynamic Tools"
NCT04934943
Humanitas Clinical and Research Center
Not Yet RecruitingSignificance of Disseminated Intravascular Coagulation Score in Mortality for Children With Shock
NCT06581172
Assiut University
RecruitingTypes of Photoplethysmographic Waves in Adult Patients with Septic Shock
NCT06786364
Hospital General de México Dr. Eduardo Liceaga
RecruitingEarly Intravenous Hydrocortisone in Sepsis
NCT06217939
Siriraj HospitalN/A
CompletedComparison of Peripheral Perfusion Indicators and Lactate Levels
NCT06727318
Gulhane Training and Research Hospital
RecruitingEarly Severe Illness TrAnslational BioLogy InformaticS in Humans
NCT05591924
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not Yet RecruitingIntravenous Methylene Blue for Treating Refractory Neonatal Septic Shock
NCT06306001
Post Graduate Institute of Medical Education and Research, ChandigarhPhase 2 / Phase 3
UnknownImpact of an Echographic Algorithm on Hemodynamic Optimization in the First 4 Days of Septic Shock Management
NCT06043505
Centre Hospitalier Universitaire de NīmesN/A
RecruitingHemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK
NCT06062303
Assistance Publique - Hôpitaux de ParisN/A
CompletedMultimodal Vasopressor Strategy in Septic Shock
NCT06155812
University Medical Centre MariborPhase 2 / Phase 3
RecruitingEarly Initiated Vasopressor Therapy in the Emergency Department
NCT05931601
Odense University HospitalPhase 3
UnknownFeasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medi
NCT04910841
Centre Hospitalier Universitaire de NiceN/A
RecruitingPituitary Function After Recovery From Septic Shock Among ICU Survivors
NCT05990491
Sanjay Gandhi Postgraduate Institute of Medical Sciences
CompletedThe Value of Peripheral Arterial Resistive Index in Evaluation of Tissue Perfusion in Patients With Septic Sho
NCT05902273
Bezmialem Vakif University
CompletedProtocolized Reduction of Non-resuscitation Fluids vs Usual Care in Septic Shock Feasibility Trial
NCT05249088
Region SkaneN/A
RecruitingStudy of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting
NCT05688774
Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps
Active Not RecruitingAustralasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis
NCT04569942
Australian and New Zealand Intensive Care Research CentrePhase 3
RecruitingManagement of Shock in Children With SAM or Severe Underweight and Diarrhea
NCT04750070
International Centre for Diarrhoeal Disease Research, BangladeshPhase 3
CompletedOrange Park Out-of-Hospital Quality Improvement Study for Improving CMS Sepsis Core Measures
NCT05961137
Orange Park Medical CenterN/A
CompletedRole and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
NCT04576819
University of Florida
CompletedEffects of Hydrocortison Treatment on Angiotensin II and Angiotensin II Receptors in Patients With Septic Shoc
NCT04647552
Inonu University
Unknown20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced Hypotension
NCT05441878
Post Graduate Institute of Medical Education and Research, ChandigarhPhase 4
UnknownEfficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in P
NCT04182737
Massimo GirardisPhase 3
UnknownPeer Support for Post Intensive Care Syndrome Self-Management
NCT03788096
University of Texas at AustinN/A
CompletedFluid Overload Quantification in Septic Shock
NCT04114162
Centre Hospitalier Universitaire de Besancon
UnknownEarly Identification of Sepsis in Children
NCT03884595
Brno University Hospital
CompletedPersonalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic
NCT04178148
Centre Hospitalier Universitaire de NīmesN/A
Active Not RecruitingEfficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
NCT04055909
InotremPhase 2
UnknownPostoperative Respiratory Abnormalities
NCT04079829
Efficacy Care R&D Ltd
UnknownFluid REsponsiveness and Arterial ELASTANCE in Patients With Septic Shock or After Aortic Surgery
NCT04388267
Central Hospital, Nancy, France
UnknownUsefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit Admission
NCT03831022
Hôpital Necker-Enfants Malades
SuspendedNeuromuscular Electrical Stimulation and Septic Shock
NCT03193164
University of Sao PauloN/A
TerminatedVitamin C, Hydrocortisone and Thiamine for Septic Shock
NCT03592693
University of AthensPhase 2
CompletedThe Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial
NCT03333278
Australian and New Zealand Intensive Care Research CentrePhase 2
TerminatedL-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury
NCT02664753
Centre Hospitalier Universitaire de NīmesPhase 3
CompletedPragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: A Pilot Feasibility Study
NCT03340805
Children's Hospital of PhiladelphiaPhase 1
WithdrawnMidodrine During Recovery From Septic Shock
NCT02771158
Northwell HealthPhase 4
CompletedSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM (Nangibotide) in Patients Wit
NCT03158948
InotremPhase 2
CompletedFluid Responsiveness in HFNC Patients
NCT03817996
Hospital Universitari Vall d'Hebron Research Institute
WithdrawnThiamine Supplementation in Patients With Septic Shock
NCT03122678
The Cleveland ClinicPhase 1
WithdrawnEffect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Sh
NCT02609152
Centre Hospitalier Universitaire de NīmesPhase 3
CompletedTargeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock
NCT02579525
Helsinki University Central HospitalN/A
TerminatedEffect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock
NCT02716597
Alexander Flannery, 859-323-4011Phase 1
CompletedStrain Echocardiography During Septic Shock : an Observational Pilot Study
NCT03663192
Centre Hospitalier Universitaire de Nīmes
CompletedPlace of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic Dysf
NCT02899897
Centre Hospitalier Universitaire, Amiens
WithdrawnNOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock
NCT02454348
University of ArkansasPhase 4
CompletedClinical Practice Guidelines and Impact of Audit and Feedback in the Emergency Department
NCT02427048
Denver Health and Hospital AuthorityN/A
TerminatedSepsis Assessment in Belgian Emergency Rooms
NCT02424721
Axis Shield Diagnostics Ltd
CompletedAnticholium® Per Se
NCT03013322
University Hospital HeidelbergN/A
CompletedBalanced Salt Solution VS. Normal Saline Solution in Septic Shock
NCT02336620
Ramathibodi HospitalPhase 3
UnknownPilot Study: Echocardiographic and Hemodynamic Effects of Esmolol in Septic Shock Patients
NCT02842983
Peking Union Medical College HospitalPhase 2 / Phase 3
TerminatedOptimization of Fluid Therapy in Sepsis by a Passive Leg Raising Test
NCT02301585
Karolinska InstitutetN/A
TerminatedCOMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2
NCT01639664
Gruppo Italiano per la Valutazione degli Interventi in Terapia IntensivaN/A
UnknownPolydatin Injectable (HW6) for Shock Treatment
NCT01780129
Neptunus Pharmaceuticals Inc.Phase 2
CompletedCan Shock Indices Be Prognostic Indicators in Sepsis/Septic Shock?
NCT06415006
Başakşehir Çam & Sakura City Hospital
WithdrawnSelenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients
NCT01601938
Gil Joon SuhPhase 2
CompletedMitochondrial Function of Immune Cells in Sepsis
NCT01600989
Insel Gruppe AG, University Hospital Bern
CompletedEmergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis Trial
NCT01453270
National University Hospital, SingaporeN/A
UnknownHemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients Wit
NCT01213914
American Burn AssociationN/A
CompletedMedical Education for Sepsis Source Control and Antibiotics
NCT01187134
Center for Sepsis Control and Care, GermanyN/A
CompletedStudy of Progression of Community Acquired Pneumonia in the Hospital
NCT02782013
Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps
CompletedProspective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Predicti
NCT01231672
Centre Hospitalier Universitaire de Nīmes
TerminatedCOMPACT - COMbining Plasma-filtration and Adsorption Clinical Trial
NCT00332371
Gruppo Italiano per la Valutazione degli Interventi in Terapia IntensivaN/A
CompletedStrategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock
NCT01310790
Chinese Septic Shock NetworkPhase 4
UnknownProtocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907
National Institute of General Medical Sciences (NIGMS)N/A
UnknownObservational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
NCT00258869
National Center for Genome Resources
CompletedHaemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)
NCT00241228
University Hospital, BordeauxN/A
CompletedTryptophan, Serotonin and Kynurenine in Septic Shock
NCT00684736
Versailles Hospital
CompletedCorticosteroid Therapy of Septic Shock - Corticus
NCT00147004
Hadassah Medical OrganizationPhase 3
CompletedA Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
NCT00046072
Eisai Inc.Phase 2
CompletedComparison of Vasopressin and Other Pressors in Septic Shock
NCT00269685
Université de SherbrookePhase 2 / Phase 3
CompletedImpact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis
NCT00406198
Hopital LariboisièrePhase 4
CompletedIbuprofen in Sepsis Study
NCT00000574
Vanderbilt UniversityPhase 3